AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32540624 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet
Number of subjects: 14
Study 32540624 — intervention group
Group type: EXPERIMENTAL
Intervention: Handlebars
Number of subjects: 14
Study 32540624 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg Retro‐reflectors
Number of subjects: 14
Study 34042566 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (20 Gy in five fractions or 30 Gy in 10 fractions)
Number of subjects: 220
Study 34042566 — intervention group
Group type: COMPARATOR
Intervention: Usual care (stent insertion alone)
Number of subjects: 220
Study 34042566 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam radiotherapy
Number of subjects: 220
Study 34042566 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 220
Study 32487334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injection
Number of subjects: 56
Study 32487334 — intervention group
Group type: EXPERIMENTAL
Intervention: Grommet placement with dexamethasone delivery followed by dexamethasone ear drop application
Number of subjects: 56
Study 36449421 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Focused Concentration and Attention Learning (intervention)
Number of subjects: 0
Study 36449421 — intervention group
Group type: COMPARATOR
Intervention: Enhanced conventional driver's education (control)
Number of subjects: 0
Study 33095038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivacaftor
Number of subjects: 38
Study 33095038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 32530412 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment with an early warning system for serum creatinine rise, immediate specialist consultation, and issuance of a patient kidney passport.
Number of subjects: 26
Study 32530412 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (intervention group)
Number of subjects: 26
Study 32530412 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 26
Study 35551757 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat diet (HF; 36% calories from saturated fat)
Number of subjects: 12
Study 35551757 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell deletion (CD247 KO) with high fat diet
Number of subjects: 12
Study 35551757 — intervention group
Group type: COMPARATOR
Intervention: Control normal fat diet (NF; 7.2% calories from fat)
Number of subjects: 12
Study 32100212 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP
Number of subjects: 360
Study 32100212 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein
Number of subjects: 360
Study 33496535 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 59
Study 33496535 — intervention group
Group type: COMPARATOR
Intervention: Myofascial manipulation
Number of subjects: 59
Study 33496535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 32370822 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal ablation
Number of subjects: 59
Study 32370822 — intervention group
Group type: COMPARATOR
Intervention: Surgical liver resection
Number of subjects: 59
Study 35466595 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week multicomponent positive psychology intervention (MPPI)
Number of subjects: 220
Study 35466595 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study 33476107 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective and Sensory Psychotherapy Protocol (ASPP)
Number of subjects: 60
Study 33476107 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 32108398 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard image analysis
Number of subjects: 65
Study 32108398 — intervention group
Group type: EXPERIMENTAL
Intervention: Subregional analysis (0-30% short T2 *)
Number of subjects: 65
Study 32108398 — intervention group
Group type: EXPERIMENTAL
Intervention: Subregional analysis (30-60% short T2 *)
Number of subjects: 65
Study 32108398 — intervention group
Group type: EXPERIMENTAL
Intervention: Subregional analysis (60-100% short T2 *)
Number of subjects: 65
Study 32108398 — intervention group
Group type: EXPERIMENTAL
Intervention: Biexponential fitting
Number of subjects: 65
Study 32108398 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability assessment
Number of subjects: 65
Study 36201383 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback group (received sleep feedback messages)
Number of subjects: 31
Study 36201383 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback group
Number of subjects: 31
Study 36201383 — intervention group
Group type: COMPARATOR
Intervention: Control group (did not receive sleep feedback messages)
Number of subjects: 31
Study 34151444 — intervention group
Group type: EXPERIMENTAL
Intervention: COOL Passport mobile healthcare application (n=49)
Number of subjects: 143
Study 34151444 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Promotion Cloud system with game-based interactive platforms and COOL Passport (n=47)
Number of subjects: 143
Study 34151444 — intervention group
Group type: COMPARATOR
Intervention: Standard-care control group (n=47)
Number of subjects: 143
Study 36356999 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care treatment for low-risk BCCs.
Number of subjects: 272
Study 36356999 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment arm with close monitoring using multispectral dermoscopy, reflectance confocal microscopy, and high-definition optical coherence tomography.
Number of subjects: 272
Study 36356999 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment arm (control).
Number of subjects: 272
Study 36356999 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm.
Number of subjects: 272
Study 33555548 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted serum creatinine (sCr) in European population
Number of subjects: 84894
Study 33555548 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted serum creatinine (sCr) in East Asian population
Number of subjects: 84894
Study 32149427 — intervention group
Group type: EXPERIMENTAL
Intervention: VY‐AADC01 administration
Number of subjects: 13
Study 32149427 — intervention group
Group type: COMPARATOR
Intervention: Levopoda infusions pre-VY‐AADC01
Number of subjects: 13
Study 32149427 — intervention group
Group type: COMPARATOR
Intervention: Levopoda infusions post-VY‐AADC01
Number of subjects: 13
Study 32735112 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone Ester (KE) 65 g
Number of subjects: 9
Study 32735112 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate (BIC) 300 mg·kg‐1 body weight
Number of subjects: 9
Study 32735112 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone Ester (KE) + Bicarbonate (BIC)
Number of subjects: 9
Study 32735112 — intervention group
Group type: COMPARATOR
Intervention: Control drink (CON)
Number of subjects: 9
Study 32692763 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition of circ-PLXNA1
Number of subjects: 0
Study 32692763 — intervention group
Group type: COMPARATOR
Intervention: si-CTNNB1 transfection
Number of subjects: 0
Study 35292258 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion
Number of subjects: 159
Study 35292258 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile perfusion
Number of subjects: 159
Study 35429955 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (2 g) administered 1 hour before and 6 hours after ERCP
Number of subjects: 270
Study 35429955 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline) administered 1 hour before and 6 hours after ERCP
Number of subjects: 270
Study 35429955 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (2 g) in high risk patients
Number of subjects: 270
Study 35429955 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (2 g)
Number of subjects: 270
Study 34081012 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform + Coach
Number of subjects: 828
Study 34081012 — intervention group
Group type: COMPARATOR
Intervention: Platform Only
Number of subjects: 828
Study 34081012 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform Only or Platform + Coach
Number of subjects: 828
Study 35610606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on independent prognostic factors (surgery, AJCC stage, laterality, tumor size, histological grade)
Number of subjects: 1375
Study 35610606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 1375
Study 33642833 — intervention group
Group type: EXPERIMENTAL
Intervention: GEP-MiNEN
Number of subjects: 46
Study 33642833 — intervention group
Group type: COMPARATOR
Intervention: NEC
Number of subjects: 46
Study 33642833 — intervention group
Group type: COMPARATOR
Intervention: Poorly differentiated adenocarcinoma
Number of subjects: 46
Study 32624476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensemble AI model using combinations of fully connected neural networks with the synthetic minority oversampling technique algorithm
Number of subjects: 1681
Study 36126736 — intervention group
Group type: EXPERIMENTAL
Intervention: Real respirator
Number of subjects: 128
Study 36126736 — intervention group
Group type: COMPARATOR
Intervention: Sham respirator
Number of subjects: 128
Study 32046611 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 12
Study 35472497 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mm Hg INP treatment
Number of subjects: 62
Study 35472497 — intervention group
Group type: COMPARATOR
Intervention: 10 mm Hg INP treatment (sham control)
Number of subjects: 62
Study 36482694 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 95
Study 36482694 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 95
Study 36482694 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 95
Study 33225810 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom carbon ankle-foot orthosis aligned in more dorsiflexion than clinically provided
Number of subjects: 24
Study 33225810 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom carbon ankle-foot orthosis aligned in more plantarflexion than clinically provided
Number of subjects: 24
Study 33225810 — intervention group
Group type: COMPARATOR
Intervention: Control group (uninjured individuals)
Number of subjects: 24
Study 36096826 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine
Number of subjects: 1540
Study 36096826 — intervention group
Group type: COMPARATOR
Intervention: 4% chlorhexidine
Number of subjects: 1540
Study 36096826 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1540
Study 34273910 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirically-based description
Number of subjects: 155
Study 34273910 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic description
Number of subjects: 155
Study 34273910 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotionally-based description
Number of subjects: 155
Study 34273910 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing arguments for utilizing PE
Number of subjects: 155
Study 34273910 — intervention group
Group type: EXPERIMENTAL
Intervention: Not writing arguments for utilizing PE
Number of subjects: 155
Study 33714746 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide in addition to standard care
Number of subjects: 7141
Study 33714746 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to standard care
Number of subjects: 7141
Study 33714746 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care
Number of subjects: 7141
Study 32955752 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Resistance Training with Instability (ARTI), n = 17
Number of subjects: 32
Study 32955752 — intervention group
Group type: COMPARATOR
Intervention: Traditional motor rehabilitation (control), n = 15
Number of subjects: 32
Study 32955174 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 256
Study 32955174 — intervention group
Group type: COMPARATOR
Intervention: Control therapy (physician's choice of enzalutamide or abiraterone plus prednisone)
Number of subjects: 256
Study 33504345 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-therapy group (DMARDs plus glucocorticoids)
Number of subjects: 56
Study 33504345 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GC or DMARDs)
Number of subjects: 56
Study 32034969 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 0
Study 32034969 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 35428281 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST pACP intervention (four ACP conversation sessions with a trained facilitator)
Number of subjects: 0
Study 35428281 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST pACP intervention
Number of subjects: 0
Study 35978272 — intervention group
Group type: EXPERIMENTAL
Intervention: Engager plus usual care
Number of subjects: 280
Study 35978272 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 280
Study 33176960 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking plate (group L, n = 45)
Number of subjects: 90
Study 33176960 — intervention group
Group type: COMPARATOR
Intervention: Nonlocking plate (group N, n = 45)
Number of subjects: 90
Study 32284175 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation
Number of subjects: 0
Study 32284175 — intervention group
Group type: COMPARATOR
Intervention: Current management recommendations for patients with AF and high CHA2DS2-Vasc score
Number of subjects: 0
Study 34739974 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular Phase (FP) intervention: quit date set 6-8 days post onset of menses, nicotine replacement therapy transdermal patch for 4 weeks, telephone-based counseling for 6 weeks
Number of subjects: 119
Study 34739974 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SC): no menstrual timing of quit date, nicotine replacement therapy transdermal patch for 4 weeks, telephone-based counseling for 6 weeks
Number of subjects: 119
Study 34739974 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FP and SC)
Number of subjects: 119
Study 32447092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive functioning assessed at baseline (executive functions, working memory, premorbid functioning)
Number of subjects: 173
Study 32447092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive domains related to long-term remission status
Number of subjects: 173
Study 32447092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive profile in coexistence with long-term non-remission
Number of subjects: 173
Study 35123461 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine treatment for 8 weeks
Number of subjects: 111
Study 35123461 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 111
Study 33059754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin treatment
Number of subjects: 32
Study 33059754 — intervention group
Group type: COMPARATOR
Intervention: Control (uninfected subjects)
Number of subjects: 32
Study 35497697 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine plus midazolam (B/M)
Number of subjects: 120
Study 35497697 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal bupivacaine plus normal saline (B/S)
Number of subjects: 120
Study 33861440 — intervention group
Group type: COMPARATOR
Intervention: Metformin (500 mg three times daily)
Number of subjects: 100
Study 33861440 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelles (80 mg/day) + Metformin (500 mg three times daily)
Number of subjects: 100
Study 36308355 — intervention group
Group type: EXPERIMENTAL
Intervention: Short hydration
Number of subjects: 30
Study 36308355 — intervention group
Group type: COMPARATOR
Intervention: Conventional hydration
Number of subjects: 30
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathology diagnosis of EoE
Number of subjects: 111
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of EoE
Number of subjects: 111
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Coexisting conditions
Number of subjects: 111
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal dilatation
Number of subjects: 111
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton-pump inhibitor treatment
Number of subjects: 111
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation steroids prescription
Number of subjects: 111
Study 34471483 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal radiology
Number of subjects: 111
Study 36153442 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive pomace oil (OPO)
Number of subjects: 0
Study 36153442 — intervention group
Group type: COMPARATOR
Intervention: High-oleic acid sunflower oil (HOSO)
Number of subjects: 0
Study 34321297 — intervention group
Group type: EXPERIMENTAL
Intervention: PediAppRREST app
Number of subjects: 315
Study 34321297 — intervention group
Group type: COMPARATOR
Intervention: CtrlPALS+ (PALS pocket reference card)
Number of subjects: 315
Study 34321297 — intervention group
Group type: COMPARATOR
Intervention: CtrlPALS- (no cognitive aid)
Number of subjects: 315
Study 32185573 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 2-g in 50 mL physiological saline solution
Number of subjects: 50
Study 32185573 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 50
Study 36029105 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant RBD-based protein subunit vaccine (Noora vaccine) 80 µg
Number of subjects: 70
Study 36029105 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant RBD-based protein subunit vaccine (Noora vaccine) 120 µg
Number of subjects: 70
Study 33066990 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-degree reverse Trendelenburg (RT) position
Number of subjects: 60
Study 33066990 — intervention group
Group type: COMPARATOR
Intervention: Horizontal (H) position
Number of subjects: 60
Study 33302740 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-min video about fertility (Intervention Group)
Number of subjects: 652
Study 33302740 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control Group)
Number of subjects: 652
Study 32651812 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas mixture with xenon (25%Xe/30%O2/45%N2)
Number of subjects: 14
Study 32651812 — intervention group
Group type: COMPARATOR
Intervention: Placebo (70%N2/30%O2)
Number of subjects: 14
Study 32991678 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg/day) for 7 days
Number of subjects: 326
Study 32991678 — intervention group
Group type: COMPARATOR
Intervention: SXT (trimethoprim 10 mg/kg/day plus sulfamethoxazole 50 mg/kg/day) for 7 days
Number of subjects: 326
Study 32991678 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 326
Study 32991678 — intervention group
Group type: COMPARATOR
Intervention: SXT
Number of subjects: 326
Study 32265473 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA isolates (53 out of 120, 44.2%)
Number of subjects: 120
Study 32265473 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA isolates
Number of subjects: 120
Study 32265473 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA isolates (CC5)
Number of subjects: 120
Study 32265473 — intervention group
Group type: EXPERIMENTAL
Intervention: CC5 MRSA isolates
Number of subjects: 120
Study 32265473 — intervention group
Group type: EXPERIMENTAL
Intervention: tst-positive MRSA isolates
Number of subjects: 120
Study 35167583 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PBM combined with intralesional administration of corticoid (IAC)
Number of subjects: 58
Study 35167583 — intervention group
Group type: COMPARATOR
Intervention: Sham PBM with intralesional administration of corticoid (IAC)
Number of subjects: 58
Study 35167583 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PBM combined with IAC
Number of subjects: 58
Study 35167583 — intervention group
Group type: COMPARATOR
Intervention: Sham PBM with IAC
Number of subjects: 58
Study 33938690 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly-L-Lactic acid (PLLA) injections combined with subcision
Number of subjects: 31
Study 33938690 — intervention group
Group type: COMPARATOR
Intervention: Saline injections combined with subcision (control group)
Number of subjects: 31
Study 33568610 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical curcumin
Number of subjects: 60
Study 33568610 — intervention group
Group type: COMPARATOR
Intervention: Topical triamcinolone acetonide
Number of subjects: 60
Study 33568610 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 35033556 — intervention group
Group type: EXPERIMENTAL
Intervention: LCD+INT (Low-Calorie Diet plus Interval Exercise)
Number of subjects: 25
Study 35033556 — intervention group
Group type: COMPARATOR
Intervention: LCD (Low-Calorie Diet)
Number of subjects: 25
Study 35765779 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 60
Study 35765779 — intervention group
Group type: COMPARATOR
Intervention: Sham Dry Needling (sham DN)
Number of subjects: 60
Study 34419636 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal extension of uterine incision
Number of subjects: 392
Study 34419636 — intervention group
Group type: COMPARATOR
Intervention: Transverse extension of uterine incision
Number of subjects: 392
Study 34817663 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide prevention video featuring an adolescent mastering suicidal ideation
Number of subjects: 299
Study 34817663 — intervention group
Group type: COMPARATOR
Intervention: Control video unrelated to mental health
Number of subjects: 299
Study 33765656 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (integrated physical exercise, cognitive training, nutritional advice, and health education lessons) for 12 months
Number of subjects: 733
Study 33765656 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Number of subjects: 733
Study 33765656 — intervention group
Group type: COMPARATOR
Intervention: Conventional health education (control group)
Number of subjects: 733
Study 32701836 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (60 mg, BID)
Number of subjects: 200